How Gilead Profited by Slow-Walking a Promising H.I.V. Therapy
Gilead delayed a new version of a drug, allowing it [...]
Gilead delayed a new version of a drug, allowing it [...]
A worrisome scarcity of cancer drugs has heightened concerns about [...]
The suit by GenBioPro, the generic maker of mifepristone, is [...]
The state awarded a $50 million contract to produce less [...]
Vertex Pharmaceuticals is not making its drug, Trikafta, available in [...]
The agency cited Teva’s continuing supply problems as well as [...]
Durante varios años ha existido en Sudáfrica una pastilla que [...]
An injection every two months rather than a daily pill [...]
The pharmaceutical industry finances about 75 percent of the agency’s [...]
Los dermatólogos especializados en la pérdida del cabello dicen que [...]